FAMILIAL HYPERCHOLESTEROLEMIA: Making Sense of Disease Mechanisms, Patient Characteristics, and Targeted Treatments

FACULTY

Christie M. Ballantyne, MD, FACP, FACC
Chief of Cardiology
Chief of Cardiovascular Research
Professor of Medicine
Baylor College of Medicine
Houston, TX

Amy E. Levenson, MD
Assistant Professor of Pediatrics
Division of Pediatric Endocrinology
University of North Carolina School of Medicine
Chapel Hill, NC

Sarah D. de Ferranti, MD, MPH
Associate Professor of Pediatrics
Director of the Preventive Cardiology Clinic and Division Chief, Outpatient Cardiology
Boston Children’s Hospital
Harvard Medical School
Boston, MA

Linda C. Hemphill, MD
Instructor in Medicine
Harvard Medical School
Director of the LDL Apheresis Unit/Massachusetts General Hospital
Boston, MA

LEARNING OBJECTIVES

• Evaluate the panel of agents available for FH and determine their appropriateness based on type of FH, individual patient risk factors, comorbidities, and prior treatment
• Assess clinical trial evidence looking at long-standing and new therapies for the treatment of patients
  with FH
• Devise treatment plans that account for genetic aberrations impacting the activity of LDL-Rs in patients with FH

TARGET AUDIENCE

This activity is intended for lipidologists, cardiologists, and other healthcare professionals involved in the management of patients with familial hypercholesterolemia (FH).

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this enduring activity for a maximum of 0.5 AMA PRA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the enduring activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in the care of patients with familial hypercholesterolemia.
Credits: 0.5 ANCC Contact Hour

ACCREDITATION STATEMENT

Ultimate Medical Academy/Complete Conference Management (CCM) is accredited as a provider of nursing continuing professional education development by the American Nurses Credentialing Center’s Commission on Accreditation.
Awarded 0.5 contact hour of continuing nursing education of RNs and APNs.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education ACCME Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF FINANCIAL RELATIONSHIPS

CME Content Review

The content of this activity was independently peer reviewed.
The reviewer of this activity has nothing to disclose.

CNE Content Review

The content of this activity was peer reviewed by a nurse reviewer.

Douglas Cox, MSN, MHA, RN
Ultimate Medical Academy/CCM – Lead Nurse Planner

The reviewer of this activity has nothing to disclose.

Staff, Planners and Managers

The independent reviewers, staff, planners, and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests:

• Matthew Frese, General Manager of Med Learning Group has nothing to disclose.
• Christina Gallo, SVP, Educational Development for Med Learning Group has nothing to disclose.
• Lauren Welch, MA, VP, Outcomes and Accreditation for Med Learning Group has nothing to disclose.
• Chris Drury, MA, MS, MBA, Scientific and Medical Services for Med Learning Group has nothing to disclose.
• Melissa A. Johnson, Senior Program Manager for Med Learning Group has nothing to disclose.
• Amanda Jenkins, Program Manager for Med Learning Group has nothing to disclose.
• Natalie Smith, Program Coordinator for Med Learning Group has nothing to disclose.
• Aimee Meissner, Outcomes and Accreditation Coordinator for Med Learning Group has nothing to disclose.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. During the course of this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

METHOD OF PARTICIPATION

There are no fees for participating and receiving CME/CNE credit for this enduring activity. To receive CME/CNE credit participants must:

1. Read the CME/CNE information and faculty disclosures.
2. Participate in the enduring activity.
3. Complete and submit the evaluation form to Med Learning Group.

You will receive your certificate after the enduring activity.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at [email protected]

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at https://medlearninggroup.com/privacy-policy/.

AMERICANS WITH DISABILITIES ACT

Staff will be glad to assist you with any special needs. Please contact Med Learning Group prior to participating at [email protected]

RELEASED DATE: October 13, 2022
EXPIRATION DATE: October 13, 2023

Copyright © 2022 Med Learning Group. All rights reserved. These materials may be used for personal use only. Any rebroadcast, distribution, or reuse of this presentation or any part of it in any form for other than personal use without the express written permission of Med Learning Group is prohibited.